Employee Spotlight: Mikael Malmqvist
We are continuing our employee spotlight series with another profile portrait. The series portrays the story of Atlas Antibodies from the people who know it the best, the employees. This time we meet Mikael Malmquist, a principal scientist who has been with the company for over 5 years. Read on to learn about his exciting journey at the company and what some of his greatest memories are.
Hi Mikael could you list five hashtags that describe your personality / interests?
Mikael: Sure, they would be #loveforgoodfood, #science, #curiosity, #findingtheunknown, #analyticalthinking
What would you say your favorite city in the world is and why?
Mikael Malmqvist: My favorite city is London. I have spent a large part of my adult life there. I have family and many friends in and around the city, and London offers the best football (soccer) in the world.
If you could describe your role as principal scientist, how would you describe it?
Mikael Malmqvist: My role involves carrying out product development of the company’s next immunoassay test platforms. My work duties range from designing experiments, performing laboratory optimizations and developments, analyzing data and presenting at scientific meetings.
What would you say is the most exhilarating / rewarding aspect of your role?
Mikael Malmqvist: Being part of the whole chain of product development, from designing and performing the proof of concept studies to taking part in the discussions surrounding product development and launch.
Our last questions is, if you like to tell us about one of your favorite company memories?
Mikael Malmqvist: Of course, one of my favorite memories is from when Atlas Antibodies took part in the 2016 American Society of Cell Biology Meeting in San Francisco. The Human Protein Atlas launched the Cell Atlas at the meeting. The Cell Atlas contains high-resolution images for more than 12,000 human proteins characterized on a subcellular level using fluorescent confocal microscopy. At the same time, Atlas Antibodies launched their new ICC-IF platform, enabling high throughput validation of subcellular staining distribution of their ICC-recommended products. The platform was based on work that I had recently carried out. That is a great company memory of mine.